Research on Disease Control and Mental Health Status of Adolescent Asthma Patients

NCT07412119 | Not Yet Recruiting DMC

• 1 other identifier: Adolescent Asthma 001
• Study Type: observational
• Target: 460
• Locations: 0 countries
• Sites: N/A

Brief Summary

Background: Currently in China, adolescent asthma care is characterized by both undertreatment and overtreatment. Patients in this age group may exhibit negative emotions toward disease treatment and long-term control. Insufficient disease knowledge, irregular lifestyle habits, and negative attitudes toward the disease can all reduce medication adherence, affect disease control outcomes, and thereby increase the risk of severe chronic respiratory conditions and disease burden in adulthood. Objectives: To assess disease control status in adolescent asthma patients, evaluate the psychological well-being of patients and their family members, and understand patients' self-management skills and readiness for transition to adulthood. Procedures: Eligible participants will complete a series of assessment questionnaires through the Youran Huxi mobile application, including questionnaires on asthma control, physical activity, psychological health, self-management behaviors, and transition readiness. The study period is 12 months; the baseline assessment involves one-time completion of written questionnaires with no interim follow-up visits. The study does not intervene in clinical diagnosis or treatment decisions.

Conditions

Asthma (Diagnosis); Adolescent - Emotional Problem

Keywords

Asthma; adolescent; mental health

Outcome Measures

Primary Outcomes (2)

• anxiety state

  Total scores on the Screen for Childhood Anxiety and Related Emotional Disorders (SCARED) ranging from 0 to 24 are considered within the non-clinical range, indicating minimal anxiety symptoms. SCARED total scores of 25-41 indicate mild to moderate anxiety symptoms. Scores of 42 or above suggest moderate to severe anxiety symptoms, indicating probable anxiety disorder.

  From the diagnosis of asthma to the end of this survey at 12month

• depression state

  A score of 16 to 19 on the Child Depression Scale (CDI) indicates mild depressive symptoms, and attention should be paid to psychological state. A score of 20 to 24 indicates moderate depressive symptoms. A score of 25 or above indicates severe depressive symptoms, suggesting the possible presence of depressive disorders.

  From the diagnosis of asthma to the end of this survey at 12month

Secondary Outcomes (2)

• disease control level

  From the 4 weeks prior to enrollment to the end of this survey at 12month

• Adolescent readiness for the transition period of asthma

  From the diagnosis of asthma to the end of this survey at 12month

Study Arms (1)

Adolescent asthma patients

Adolescents diagnosed with asthma

Other: Eligible participants will complete a battery of assessment questionnaires

Interventions

Eligible participants will complete a battery of assessment questionnaires OTHER

Data on demographic characteristics, asthma control status, anxiety and depression symptoms, self-management self-efficacy, and transition readiness were collected via standardized questionnaires

Adolescent asthma patients

Eligibility Criteria

• Age: 12 Years - 18 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

This study recruited children with asthma and their parents from the hospital outpatient clinic as research participants. The inclusion criteria were: meeting the GINA 2025 diagnostic criteria for asthma; children aged 12-18 years; and both parents and children provided informed consent and were able to complete the questionnaires. The exclusion criteria were: children with other respiratory diseases such as bronchiectasis, bronchiolitis, cystic fibrosis, or pneumonia; and those with other chronic systemic diseases including diabetes, kidney disease, lupus erythematosus, skin diseases, epilepsy, heart disease, or arthritis.

You may qualify if:

• Meet the asthma diagnostic criteria of GINA 2025
• Age 12 to 18 years old
• The parents and the child patient agreed and filled out the questionnaire completely.

You may not qualify if:

• Children with other respiratory diseases such as bronchiectasis, bronchiolitis, cystic fibrosis and pneumonia
• Combined with chronic diseases of other systems

Sponsors & Collaborators

• Beijing Children's Hospital: lead

MeSH Terms

Conditions

Asthma; Disease; Psychological Well-Being

Condition Hierarchy (Ancestors)

Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Personal Satisfaction; Behavior

Central Study Contacts

Kunling Prof.Shen

CONTACT

0755-83008286; hanpengonly1@163.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Doctor

Study Record Dates

• First Submitted: February 6, 2026
• First Posted: February 17, 2026
• Study Start: April 1, 2026
• Primary Completion (Estimated): October 1, 2027
• Study Completion (Estimated): December 1, 2027
• Last Updated: February 17, 2026

Record last verified: 2026-02